Summary: Structural Variations (SV) are a major source of variability in the human genome that shaped its actual structure during evolution. Moreover, many human diseases are caused by SV, highlighting the need to accurately detect those genomic events but also to annotate them and assist their biological interpretation. Therefore, we developed AnnotSV that compiles functionally, regulatory and clinically relevant information and aims at providing annotations useful to (i) interpret SV potential pathogenicity and (ii) filter out SV potential false positive. In particular, AnnotSV reports heterozygous and homozygous counts of single nucleotide variations (SNVs) and small insertions/deletions called within each SV for the analyzed patients, this genomic information being extremely useful to support or question the existence of an SV. We also report the computed allelic frequency relative to overlapping variants from DGV (MacDonald et al., 2014) , that is especially powerful to filter out common SV. To delineate the strength of AnnotSV, we annotated the 4751 SV from one sample of the 1000 Genomes Project, integrating the sample information of four million of SNV/indel, in less than 60 s.
Introduction
Next-Generation Sequencing (NGS) technologies have been widely used to identify the molecular causes of inherited human diseases. It reveals with a single assay the extreme variability of the human genome composed of millions of Single Nucleotide Variations (SNV), small insertions and deletions (indel) as well as thousands of structural variations (SV) (Sudmant et al., 2015) . SV are an important cause of genetic diseases that are routinely detected by array-based methods. Nevertheless, compared to whole genome sequencing, those methods are of low resolution and noisy signal can make detection of small SV more difficult (Engelhardt et al., 2017) . Since a decade, more than 150 tools (Supplementary Table S1 ) have been developed to detect SV from NGS data by using different algorithms, each with their own strengths and weaknesses. However, SV prediction programs often show a high false positive detection rate (Samarakoon et al., 2016) , that requires careful inspection by the user. Thus, apart from the difficulty to properly detect those genomic events with NGS technologies, one of the current challenges is to enhance the automatic analysis of these anomalies. Existing annotation tools provide functionally, regulatory and/or clinically relevant information using multiple datasets in order to highlight potentially significant findings and prioritize candidates for further analyses (Erikson et al., 2015; Makarov et al., 2012; Samarakoon et al., 2016; Zhang et al., 2015; Zhao and Zhao, 2013) . Nevertheless, several crucial annotations sources are still lacking from the existing tools such as the compiled patient's own information (SNV/indel) or 
Overview of AnnotSV
AnnotSV can be accessed from the well documented http://lbgi.fr/ AnnotSV/ website. It is a command-line tool written in the Tcl programming language, which can be executed on a variety of operating systems and integrated in any automatic NGS analysis pipeline.
Starting with SV's genomic co-ordinates called from NGS data and available in a standard VCF or BED file, AnnotSV performs the annotation process first by identifying the genomic overlaps between the input and the annotation features. The overlapping criteria can be either a reciprocal or non-reciprocal overlap (user defined) between the SV and the annotation. These annotations can be performed using either the GRCh37 or GRCh38 build of the human genome. Second, annotations linked to the gene name are also reported. Finally, to offer the most comprehensive and accurate annotation, AnnotSV generates for each SV (i) one annotation based on the full length SV and (ii) one annotation for each gene within the SV. Indeed, this latter annotation is extremely powerful to shorten the identification of mutation in a specific gene. The output is produced as a tab-separated file that can be directly opened in a spreadsheet program. Three different types of annotations are provided, which are summarized here and detailed in Table 1: -A genomic based annotations, providing annotations for the overlapping features with the annotated SV. These annotations include the definition of the genes/transcripts from RefSeq [i.e. ID, Coding DNA Sequence (CDS), transcript length, SV co-ordinates within the gene], DGV, DECIPHER (Firth et al., 2009) , 1000 Genomes project (phase 3) (Sudmant et al., 2015) , OMIM (Hamosh et al., 2000) , gene intolerance from the ExAC dataset (Lek et al., 2016) , haploinsufficiency (Huang et al., 2010) , promoters, Topologically Associating Domain, GC content, repeated sequences . . ..
In particular, we used the DGV Gold Standard dataset by reporting SV identifiers and by calculating the counts of unique samples with gains and losses, the number of non-redundant samples tested in the related studies and the subsequent relative frequency (Supplementary Fig. S1 ). These annotations are especially powerful for filtering common SV.
-A patient based annotation, using the SNV and indel variations identified from the patient's NGS data using a VCF file as an input. The numbers of homozygous and heterozygous variants covered by a SV are reported and can be used to filter out false positives ( Supplementary Fig. S2 ). Indeed, first, false positive homozygous deletions can be highlighted by identifying SNV/indel called within the SV. Second, false positive heterozygous deletions can be identified thanks to the presence of heterozygous SNV/indel in the overlapping region. Finally, the presence of only homozygous SNV/indel can be a way to confirm the heterozygous deletions.
-A custom based annotation dedicated to the users' specific practice via a custom tab-separated file. For example, one could add each gene transmission mode, known genes in a given group of pathologies. . .
Performance testing
In order to assess the performance of AnnotSV, the genome data from one sample (HG00096) of the 1000 Genome Project was downloaded and annotated. In total, 4, 751 SV ranging in size from 50 bp to 1.2 Mb were annotated based on the GRCh37 build of the human genome, integrating also the information from the VCF files of four million of SNV/Indel (Supplementary Materials). As a result, 38% of the SV overlapped a least one gene and 52% overlapped at least one SV from DGV, among which 77% are frequents (present in more than 1% of the samples tested). AnnotSV completed the annotation for these SV in less than 60 s on a Linux x86_64 server (Xeon E5-2670). High annotation speed makes AnnotSV suitable for high-throughput sequencing facilities, making it practical to handle hundreds of human genomes in a day.
Conclusion
In summary, we developed a new tool for annotating human SV identified from NGS dataset. This tool reduces the time and efforts required to highlight disease-causing SV and so improve the clinical utility of SV detection in NGS data. These analyses are a crucial step to get a better understanding of the human genome and a pre-requisite towards personalized medicine.
